C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 405/06 (2006.01) A61K 31/36 (2006.01) A61K 31/405 (2006.01)
Patent
CA 2308478
The invention provides S-(+)-3-{1-(1,3-benzodioxol- 5-yl)-2-[(2-methoxy-4-methylphenyl)sulfonylamino]-2- oxoethyl)-1-methyl-1H-indole-6-carboxylic acid, represented by the following formula: (see formula I) which is substantially free from its (R)-(-)enantiomer, and pharmaceutically acceptable derivatives thereof. The compound is useful in the treatment of inter alia acute renal failure, restenosis and pulmonary hypertension.
L'invention concerne un acide S-(+)-3-{ 1,3-benzodioxol -5-yl)-2-[ (2-méthoxy-4- méthylphényl)sulfonylamino] -2-oxoéthyl }-1-méthyl -1H-indole- 6 carboxylique représenté par la formule (a) qui est sensiblement exempt de son (R)-(-)-énantiomère et ses dérivés pharmaceutiquement acceptables. Les composés sont utiles dans le traitement notamment d'insuffisance rénale aiguë, de resténose et d'hypertension pulmonaire.
Challenger Stephen
Dack Kevin Neil
Derrick Andrew Michael
Dickinson Roger Peter
Ellis David
Pfizer Inc.
Smart & Biggar
LandOfFree
Indole derivatives useful as endothelin receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives useful as endothelin receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives useful as endothelin receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1418080